REGLAN

This brand name is authorized in Albania, Croatia, United States, South Africa

Active ingredients

The drug REGLAN contains one active pharmaceutical ingredient (API):

1 Metoclopramide
UNII W1792A2RVD - METOCLOPRAMIDE HYDROCHLORIDE

The action of metoclopramide is closely associated with parasympathetic nervous control of the upper gastro-intestinal tract where it has the effect of encouraging normal peristaltic action. This provides for a fundamental approach to the control of those conditions where disturbed gastrointestinal motility is a common underlying factor.

Read about Metoclopramide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
REGLAN Tablet FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A03FA01 Metoclopramide A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03F Propulsives → A03FA Propulsives
Discover more medicines within A03FA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AL Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor Identifier(s): 8/6
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-248373765, HR-H-390500641
Country: US FDA, National Drug Code Identifier(s): 62559-165, 62559-166
Country: ZA Health Products Regulatory Authority Identifier(s): R/5.7.2/88, R/5.7.2/89, S/5.7.2/169

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.